The 3rd World Parkinson Congress is a four-day scientific conference designed to

描述（由申请人提供）：第三届世界帕金森大会（WPC 2013）的目的是解决帕金森病（PD）多方面问题的全球对话的持续需求，并提出解决方案，包括新的研究方法和更好的PD患者护理模式。2013年世界帕金森病大会将于2013年10月1日至4日在加拿大蒙特利尔举行，这是帕金森病领域唯一一次将整个帕金森病社区聚集在一起进行高水平科学和非专业会议的国际会议。参加会议的代表包括来自近60个国家的神经科学家、医生、PD患者、护理人员、护士、康复专家、政府代表和倡导团体成员。为期四天的课程重点介绍了PD科学的进步以及对PD患者的护理模式。让美国的研究人员了解世界其他地区取得的科学进步，将有助于他们探索新的想法，建立他们原本可能不会考虑的合作。PD社区的广泛支持和参与（已经有超过140个合作组织和少数赞助商）表明，WPC是这些广泛团体会面和建立合作的合适场所。它将允许和鼓励卫生专业人员，研究人员，PD患者和护理人员之间的互动，否则他们可能不会见面。这种思想的相互数字化将刺激新的创新研究，为未满足的需求找到潜在的解决方案，推进PD患者的治疗，并激励代表们继续他们的工作。包括PD患者（PwP）在内的49名委员会成员设计了一个关于PD独特方面的详细计划，以深化研究人员/临床医生对PD研究的承诺，并促进对PD较少研究方面的研究。该计划有望使残疾人和护理人员接触到研究，并增加参与临床试验的兴趣。演讲者

DESCRIPTION (provided by applicant): The purpose of the 3rd World Parkinson Congress (WPC 2013) is to address an ongoing need for worldwide dialogue on the multifaceted problems of Parkinson's disease (PD) and to propose solutions, including new approaches to research and better models of care for people with PD. The WPC 2013, to be held from October 1-4, 2013, in Montreal, Canada, is the only international meeting in the field of Parkinson's that brings the whole PD community together for high-level scientific and lay sessions. Delegates at the meeting represent neuroscientists, physicians, people with PD, caregivers, nurses, rehabilitation specialists, government representatives, and members of the advocacy community from nearly 60 countries. The four-day program highlights advancements in the science of PD and models of care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not have considered. Broad support and involvement from the PD community (already over 140 partnering organizations and a handful of sponsors) shows that the WPC is the right venue for these widespread groups to meet and build collaborations. It will allow and encourage interactions between health professionals, researchers, and people with PD and caregivers who might not otherwise meet. Such inter-digitation of ideas will spur new innovative research, identify potential solutions to unmet needs, advance therapies for people with PD and inspire delegates to continue their work. Forty-nine committee members, including people with PD (PwP), designed an elaborate program about unique aspects of PD to deepen the commitment of researchers/clinicians to PD research and foster research on less studied aspects of PD. The program is expected to expose PwPs and caregivers to research and increase interest in participating in clinical trials. Speakers are being invited from all areas of the PD community with sessions formatted to maximize the learning potential and dialogue, including large and moderately sized as well as more intimate workshops. The morning plenaries will look at the death of neurons, non-motor manifestations, and new views on management of PD. This will set the stage daily for further discussion in later sessions. There will be both Scientific and Living with Parkinson's posters displayed each day. Poster sessions and tours are designed to maximize interaction among the delegates. The four most outstanding posters each day in basic and clinical research, clinical therapeutics and quality of life will be presented in an oral "Hot Topics" session and poster tours will be held, paying keen attention to the most promising work in the field and to increase dialogue and collaboration in the community.